DT Investment Partners LLC Decreases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

DT Investment Partners LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,709 shares of the healthcare conglomerate’s stock after selling 150 shares during the quarter. DT Investment Partners LLC’s holdings in UnitedHealth Group were worth $1,868,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Ascension Capital Advisors Inc. bought a new stake in UnitedHealth Group in the third quarter valued at $216,000. Bellecapital International Ltd. boosted its holdings in shares of UnitedHealth Group by 1.4% during the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock valued at $7,277,000 after buying an additional 193 shares in the last quarter. Great Valley Advisor Group Inc. boosted its holdings in shares of UnitedHealth Group by 5.8% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock valued at $17,292,000 after buying an additional 1,884 shares in the last quarter. Rise Advisors LLC raised its position in shares of UnitedHealth Group by 326.0% in the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock worth $112,000 after purchasing an additional 163 shares during the last quarter. Finally, Gradient Investments LLC raised its position in UnitedHealth Group by 6.3% in the 4th quarter. Gradient Investments LLC now owns 84,278 shares of the healthcare conglomerate’s stock worth $44,370,000 after buying an additional 5,023 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on UNH. Truist Financial restated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a research note on Wednesday. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Piper Sandler increased their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday. Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday. Finally, Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a report on Wednesday. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Stock Up 1.6 %

Shares of UnitedHealth Group stock traded up $7.95 during trading on Friday, hitting $501.13. 6,618,600 shares of the stock traded hands, compared to its average volume of 5,233,813. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The firm has a market cap of $462.01 billion, a P/E ratio of 30.64, a price-to-earnings-growth ratio of 1.35 and a beta of 0.54. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The stock’s fifty day simple moving average is $488.63 and its 200 day simple moving average is $515.13.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the previous year, the company posted $6.26 earnings per share. The company’s revenue was up 8.6% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.74 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.